ITFG3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68926
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: REEVSGHLYSGSTGHQIGLRGSLGVDGESGFLLHVTRTGAHYILFPCASSLCGCSVKGLYEKVTGSGGPFKSDPHWESMLNATTRRM
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ITFG3 Antibody
Immunohistochemistry: ITFG3 Antibody [NBP2-68926]
Immunohistochemistry: ITFG3 Antibody [NBP2-68926] - Immunohistochemical staining of human duodenum shows strong membranous positivity in glandular cells.Applications for ITFG3 Antibody
Application
Recommended Usage
Immunohistochemistry
1:20 - 1:50
Immunohistochemistry-Paraffin
1:20 - 1:50
Application Notes
Recommended conditions for IHC,Retrieval method: HIER pH6
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ITFG3
Alternate Names
C16orf9, chromosome 16 open reading frame 9, DKFZP761D0211, FLJ32603, gs19, integrin alpha FG-GAP repeat containing 3, protein ITFG3
Gene Symbol
ITFG3
Additional ITFG3 Products
Product Documents for ITFG3 Antibody
Product Specific Notices for ITFG3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...